GET A PIECE OF CAREMINDR
Founded in 2017 in Silicon Valley, CAREMINDr enables patients to have regular periodic check-ins from their doctors, a "Digital House Call " that monitors each patient's health without requiring visits to the office.
By communicating with their doctors and clinicians between office visits, and being able to easily provide important information about their conditions, patients can better work with their care team and strive to be as healthy as possible. In underserved, lower-economic populations, our technology overcomes many of the obstacles they encounter: difficulties with transportation, inaccessible appointment times, or problems involving language or familiarity with healthcare terminology.
Healthcare is enormous: tens of thousands of doctors, clinics, hospitals, and specialists.
We fully understand this, and CAREMINDr has laser-like focus on one specific segment of this industry.
Our market is the largest primary care system in the US. It serves about 29 million patients; it's been around for over 55 years --- and it's likely you've never heard of it.
It is the Federal Community Health Center program: over 1,400 locally governed, non-profit organizations that operate about 14,000 sites. They get base funding directly from Washington, this year about $6 billion.
You probably don’t know of them because their 29 million patients are mostly low-income people, covered by Medicaid. About 1/3 are under 18, including teenage moms, the rest are working-age adults, with a small percentage over 65. Some are veterans, some are uninsured, some are homeless. They come from all racial and ethnic backgrounds.
Over 55 years ago this program was implemented as a safety net for U.S. healthcare, to assure that basic services were available even in the poorest neighborhoods, so that hospital emergency rooms were not overwhelmed with patients needing everyday care.
The COVID pandemic was brutal in these communities.
In mid-2020 low-income people, especially those who were people of color, were dying at unacceptably high rates.
The main reason is that these families have more obstacles in receiving care, difficulties with transportation, food, housing, and even language.
The pandemic put a bright spotlight on this inequity, and Congress responded.
Last April, the American Rescue Plan was passed. It sent an additional $6.1 billion to the 1,400 Health Centers, and added almost a billion more in September. The 2021 Federal funding for Health Centers was over $12 billion.
With this money comes disciplined accountability. Every year each center must file a highly detailed report that lists over 100 key statistics about their patients and the care they delivered.
More importantly, each Health Center lists 20 clinical issues, showing the number of people in each category, and how well they are managing that group's condition. Strict guidelines dictate how performance is measured. Each score is then compared to the other 1,400 centers and a grade is assigned based on where they rank. This is a true quality of care report card --- and it is public.
There are also special programs that provide additional funding. Last January $90 million was awarded to about 500 Health Centers specifically to improve Hypertension. This is where CAREMINDr first entered this market.
Today we have over 30 Health Center clients who are providing nearly 40,000 blood pressure cuffs to their patients. CAREMINDr enables these Centers to regularly check in with each patient and track their progress. These Digital House Calls can instantly identify and help the patients who need attention. We enable Health Centers to exceed the performance goals set by their funding, at levels never before achieved.
Here are 5 reasons why we like this market, the Community Health Center system:
First, it is really big, about 29 million patients (source).
Second, it has enormous needs, and challenges that require new technology to overcome (source).
Third, there is a staffing crisis. Healthcare workers are exhausted or burned out and all of the centers have staff vacancies they are not able to fill. They need to get the job done with the team they have on hand; our technology is automation that performs key patient care tasks, freeing up current staff time to help solve this problem. (source).
Fourth, there is proven financial support. Significant money has been made available, focused on overcoming major problems that truly need to be addressed.
And fifth, there is accountability: mandated reporting pushes each center to take action and not delay, providing them a way to provide accurate reporting (source).
The pandemic greatly accelerated the evolution of the ways primary care can be delivered outside of traditional offices and especially to underserved vulnerable communities. We think CAREMINDr is a way to lower the cost of providing such care while improving the outcomes of care patients receive. This combination is recognizably valuable to the entities who are the financial risk-bearers in the system, from the federal government to the local community health centers.
Moreover, we are not aware of any direct competitors facilitating the Doctor-Patient communication that CAREMINDr enables for Community Health Centers; it is an underserved market.
Being able to effectively sell to the 1,400 Community Health Centers only recently became possible, when the pandemic drove the universal adoption of video business meetings.
Especially if you need to go back time after time for an ongoing condition.
In our eyes, the current system relies on too much human effort and, because of this, is inconsistent and cannot be scaled to serve large communities of patients effectively. Disadvantaged people also face problems with transportation, or the inability to find time for appointments.
This is where CAREMINDr comes in, providing an easy-to-use way for a patient to conveniently complete a short form that periodically tells their doctor key information about their condition. The questions on the form are multiple-choice or a number, so the patient does not need to compose a sentence or worry about word choice. This all occurs on a pre-set automated schedule so no check-in dates are missed.
We’re leveraging patients’ affinity for mobile technology to keep doctors informed about their chronic health conditions and adherence to treatment plans. We have seen how such communication improves the health of large patient populations at the clinics we serve.
We do this by creating automatic check-ins between doctors and their patients - we refer to it as a “Digital House Call,” built to be convenient, private, and fitting patients' schedules.
This remote patient care is designed mostly for patients who have ongoing health conditions like diabetes, high blood pressure, depression, and pregnancy. These check-ins help a doctor track how a patient is doing, keeping them up to date in case any problems come up that require intervention.
We are unique in that CAREMINDr performs at least 15 key patient care tasks typical to a doctor checking in with a patient who has a condition that lasts for an extended period (source).
We believe we are delivering value that is seldom available to our current community health center partners, with technology rarely seen in this market segment. (source).
We have signed 30 community health center clients, and have launched large-scale operations with them, initially directed at 80,000 hypertensive patients. This hypertensive cohort represents less than 20% of the 500,000 patients our clients serve each year, who themselves are a small fraction of the 1,400 community health centers nationwide (source).
For programs that have been operating for at least 3 months, our clients are achieving results that are at high-quality levels unprecedented in the industry.
Beyond hypertension, we have expanded our library of clinical management to a growing list of primary care conditions, now including diabetes, asthma, depression, COVID-19, flu, and many others.
Regarding Intellectual Property, we have ten patents in process, one of which was recently filed and is in provisional status. All the others are non-provisional and two have reached the pre-release publication-for-comment stage.
We are actively helping the providers who care for those most in need - this means Medicaid recipients, the poor, the uninsured or underinsured, veterans, and the homeless: anyone who seeks their primary care from Federally Qualified Health Centers (FQHCs) and FQHC Look-Alikes (LALs). These facilities are tasked with providing healthcare services to these underserved populations - and we are here to help.
With this in mind, we aim to be leading edge innovators in how primary care should be delivered to everyone.
CAREMINDr is here to be a large part of how all of U.S. healthcare evolves.
We not only believe to have the best technology solution to achieve these goals, but we also believe we may be one of the only vendors with a broad suite of solutions ready to go today, with a particular focus on an underserved yet increasingly well-funded market segment.
Remote patient care is a reality. Its challenge and potential in the patient population served by Community Health Centers is real and well-recognized. CAREMINDr delivers a solution.
At CAREMINDr we believe our approach to remote patient care is a game-changer for the industry. That's because CAREMINDr enables patients who need on-going care to now have their doctor regularly check-in with them through convenient "Digital House Calls ", using just their cell phone. Using technology to deliver better access and regular connection fundamentally changes how people receive care. This is a business transformation that is happening today, and we believe that our approach shows that a new level of care can be achieved, especially for underserved communities. We are fully operational today, have 30 Federal Qualified Health Centers as clients, and have filed 10 patents.
25+ years leading start-ups (four previous venture-backed companies)
Founder/CEO - Resolution Health (2007: sold to WellPoint, $150M)
- Preferred Solutions (1996: sold to PacifiCare, $32M)
- two smaller tech companies (exits: non-public acquisition)
MSEE-Stanford University; BSEE-University of Notre Dame
B.A., Economics, Swarthmore College;
M.B.A., Accounting and Finance, University of Chicago
Member of Founding team in three successful start-up companies, venture financed
B.S. - Iowa State University,
Executive MBA - University of Colorado
Dr. Irina Yermilov
Chief Medical Officer
10+ years experience in measuring cost and quality outcomes via claims & supplemental data, Consultant - UCLA Education & Research Institute
Research Resident - RAND Corporation, General Surgery Residency - UCLA
40+ Professional Publications & Abstracts
Jennifer Gillooly Viola
VP - Client Success, Eastern Region
VP -Client Success, Western Region
VP - Partnerships & Innovation
Worked with Senior Team members in a prior successful healthcare technology company.
Maximum Number of Shares Offered subject to adjustment for bonus shares
*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.
Super Early Bird Bonus
Invest within the first 7 days and receive 20% bonus shares
Early Bird Bonus
Invest within the first 30 days and receive 10% bonus shares
$500+ | Tier I
5% Bonus Shares.
$1,000+ | Tier II
15% bonus shares.
$2,500+ | Tier III
25% bonus shares.
*All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
CAREMINDr will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Non-Voting Common Stock at $1.48 / share, you will receive 110 shares of Non-Voting Common Stock, meaning you'll own 110 shares for $148. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.
Irregular Use of Proceeds
The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Inter company debt or back payments.
Members get an extra 10% shares in addition to rewards below!
a year ago
a year ago
a year ago
a year ago
Cancel anytime before 48 hours before a rolling close or the offering end date.
We want you to succeed and get the most out of your money by offering rewards and memberships!
Your info is your info. We take pride in keeping it that way!
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.